Core Viewpoint - The company announced that its Executive Director, CEO, and Chairman, Dr. Tian Wenzhi, purchased a total of 50,000 H-shares in the open market at an average price of approximately HKD 7.95 per share, representing about 0.01% of the company's total issued shares [1] Group 1 - Following the purchase, Dr. Tian holds a total of 116 million shares, which accounts for 26.90% of the company's total issued share capital as of the announcement date [1] - Dr. Tian expressed confidence in the overall development prospects and potential growth of the group [1] - Dr. Tian does not rule out the possibility of further increasing his shareholding in the company at an appropriate time, in compliance with applicable laws and regulations [1]
宜明昂科-B获执行董事田文志增持5万股H股